Rigel Pharmaceuticals (RIGL) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Q3 2025 value amounting to -$1.0 million.
- Rigel Pharmaceuticals' Other Gross PP&E Adjustments fell 15925.93% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 15925.93%. This contributed to the annual value of $107000.0 for FY2024, which is 8938.49% down from last year.
- Latest data reveals that Rigel Pharmaceuticals reported Other Gross PP&E Adjustments of -$1.0 million as of Q3 2025, which was down 15925.93% from -$1.2 million recorded in Q2 2025.
- Rigel Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $9.7 million during Q4 2022, with a 5-year trough of -$15.9 million in Q1 2021.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$1.0 million (2025), whereas its average is -$2.5 million.
- Per our database at Business Quant, Rigel Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 36619.88% in 2021 and then plummeted by 15925.93% in 2025.
- Over the past 5 years, Rigel Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at $6.8 million in 2021, then surged by 42.56% to $9.7 million in 2022, then plummeted by 89.64% to $1.0 million in 2023, then crashed by 89.38% to $107000.0 in 2024, then tumbled by 1081.31% to -$1.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$1.0 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$1.3 million for Q1 2025.